期刊文献+

艾滋病疫苗的研究进展 被引量:5

Progress in research on acquired immunodeficiency syndrome vaccine
原文传递
导出
摘要 艾滋病全称获得性免疫缺陷综合征(acquired immunodeficiency syndrome,AIDS),是由人免疫缺陷病毒(human immunodeficiency virus,HIV)感染引起的,已成为全球性健康难题。HIV通过攻击CD4^+ T细胞而破坏机体的免疫系统,且该病毒易发生突变,使相应疫苗的设计更加困难,诱导中和抗体产生的同时激发机体的细胞免疫将成为开发有效艾滋病疫苗的新思路。本文对HIV的结构特点及疫苗设计、艾滋病疫苗诱导的细胞及体液免疫作一综述,并对该疫苗的开发前景进行展望。 Acquired immunodeficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV) infection has become a worldwide health problem. Exploiting an effective HIV vaccine is an urgent task. Once human is infected by HIV-1, CD4+ T cells will be attacked and the immune system will lose the defending functions. Meanwhile, the variability of HIV makes it difficult to design the corresponding vaccines. Induction of neutralizing antibodies and cellular immunity stimulation will be a promising way to protect body from HIV invasion. This paper reviews the structural characteristics of HIV, design of AIDS vaccine, cellular and humoral immune responses induced by vaccines, as well as the prospect of vaccine development.
出处 《中国生物制品学杂志》 CAS CSCD 2016年第2期213-216,220,共5页 Chinese Journal of Biologicals
关键词 艾滋病 疫苗 Acquired immunodeficiency syndrome (AIDS) Vaccine
  • 相关文献

参考文献29

  • 1JIA Z,WANG L,CHEN R Y,et al.Tracking the evolution of HIV/AIDS in China from 1989-2009 to inform future prevention and control efforts[J].PLo S One,2011,6(10):e25671.doi:10.1371/journal.pone.0025671.
  • 2SPICER N,BOGDAN D,BRUGHA R,et al.'It's risky to walk in the city with syringes':understanding access to HIV/AIDS services for injecting drug users in the former Soviet Union countries of Ukraine and Kyrgyzstan[J].Global Health,2011,7(1):22-36.
  • 3FREY G,PENG H,RITS-VOLLOCH S,et al.A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies[J].Proc Natl Acad Sci USA,2008,105(10):3739-3744.
  • 4CHERTOVA E,BESS J W Jr,CRISE B J,et al.Envelope glycoprotein incorporation,not shedding of surface envelope glycoprotein(gp120/SU),Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus[J].J Virol,2002,76(11):5315-5325.
  • 5HAYNES B F,GILBERT P B,MCELRATH M J,et al.Immune-correlates analysis of an HIV-1 vaccine efficacy trial[J].N Engl J Med,2012,366(14):1275-1286.
  • 6SAGAR M,WU X,LEE S,et al.Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection,and these modifications affect antibody neutralization sensitivity[J].J Virol,2006,80(19):9586-9598.
  • 7WU X,ZHOU T,O'DELL S,et al.Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment[J].J Virol,2009,83(21):10892-10907.
  • 8HESSELL A J,RAKASZ E G,POIGNARD P,et al.Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers[J].PLo S Pathog,2009,5(5):e1000433.doi:10.1371/journal.ppat.1000433.
  • 9ZWICK M B,JENSEN R,CHURCH S,et al.Anti-human immunodeficiency virus type 1(HIV-1)antibodies 2F5 and 4E10require surprisingly few crucial residues in the membraneproximal external region of glycoprotein gp41 to neutralize HIV-1[J].J Virol,2005,79(2):1252-1261.
  • 10RUPRECHT C R,KRARUP A,REYNELL L,et al.MPERspecific antibodies induce gp120 shedding and irreversibly neutralize HIV-1[J].J Exp Med,2011,208(3):439-454.

同被引文献58

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部